References - iarc

2304. Puls LE, Hamous J, Morrow MS,
Schneyer A, MacLaughlin DT, Castracane
VD (1994). Recurrent ovarian sex cord
tumor with annular tubules: tumor marker
and chemotherapy experience. Gynecol
Oncol 54: 396-401.
2305. Purola E, Savia E (1977). Cytology of
gynecologic condyloma acuminatum. Acta
Cytol 21: 26-31.
2306. Pysher TJ, Hitch DC, Krous HF (1981).
Bilateral juvenile granulosa cell tumors in
a 4-month-old dysmorphic infant. A clinical,
histologic, and ultrastructural study.
Am J Surg Pathol 5: 789-794.
2307. Qiao S, Nagasaka T, Harada T,
Nakashima N (1998). p53, Bax and Bcl-2
expression, and apoptosis in gestational
trophoblast of complete hydatidiform mole.
Placenta 19: 361-369.
2308. Qizilbash AH (1976). Cystosarcoma
phyllodes with liposarcomatous stroma.
Am J Clin Pathol 65: 321-327.
2309. Qizilbash AH, Patterson MC, Oliveira
KF (1977). Adenoid cystic carcinoma of the
breast. Light and electron microscopy and
a brief review of the literature. Arch Pathol
Lab Med 101: 302-306.
2310. Quaglia MP, Brennan MF (2000). The
clinical approach to desmoplastic small
round cell tumor. Surg Oncol 9: 77-81.
2 3 1 1 . Quigley JC, Hart WR (1981).
Adenomatoid tumors of the uterus. Am J
Clin Pathol 76: 627-635.
2312. Quincey C, Raitt N, Bell J, Ellis IO
(1991). Intracytoplasmic lumina--a useful
diagnostic feature of adenocarcinomas.
Histopathology 19: 83-87.
2313. Quinn JM, McGee JO, Athanasou NA
(1998). Human tumour-associated
macrophages differentiate into osteoclastic
bone-resorbing cells. J Pathol 184: 31-
36.
2314. Quinn MA (1997). Adenocarcinoma of
the cervix--are there arguments for a different
treatment policy? Curr Opin Obstet
Gynecol 9: 21-24.
2315. Quinn MA, Oster AO, Fortune D,
Hudson B (1981). Sclerosing stromal
tumour of the ovary case report with
endocrine studies. Br J Obstet Gynaecol
88: 555-558.
2316. Raber G, Mempel V, Jackisch C,
Hundeiker M, Heinecke A, Kurzl R, Glaubitz
M, Rompel R, Schneider HP (1996).
Malignant melanoma of the vulva. Report
of 89 patients. Cancer 78: 2353-2358.
2317. Radford DM, Fair KL, Phillips NJ,
Ritter JH, Steinbrueck T, Holt MS, Donis-
Keller H (1995). Allelotyping of ductal carcinoma
in situ of the breast: deletion of loci
on 8p, 13q, 16q, 17p and 17q. Cancer Res
55: 3399-3405.
2318. Radhi JM (2000). Immunohistochemical
analysis of pleomorphic lobular carcinoma:
higher expression of p53 and
chromogranin and lower expression of ER
and PgR. Histopathology 36: 156-160.
2319. Radig K, Buhtz P, Roessner A (1998).
Alveolar soft part sarcoma of the uterine
corpus. Report of two cases and review of
the literature. Pathol Res Pract 194: 59-63.
2320. Ragnarsson-Olding BK, Nilsson BR,
Kanter-Lewensohn LR, Lagerlof B,
Ringborg UK (1999). Malignant melanoma
of the vulva in a nationwide, 25-year study
of 219 Swedish females: predictors of survival.
Cancer 86: 1285-1293.
2321. Rahilly MA, Williams AR, Krausz T, al
Nafussi A (1995). Female adnexal tumour of
probable Wolffian origin: a clinicopathological
and immunohistochemical study of
three cases. Histopathology 26: 69-74.
2322. Rajakariar R, Walker RA (1995).
Pathological and biological features of
mammographically detected invasive
breast carcinomas. Br J Cancer 71: 150-
154.
2323. Rajan JV, Marquis ST, Gardner HP,
Chodosh LA (1997). Developmental expression
of Brca2 colocalizes with Brca1 and is
associated with proliferation and differentiation
in multiple tissues. Dev Biol 184:
385-401.
2324. Rajkumar T, Franceschi S, Vaccarella
S, Gajalakshmi V, Sharmila A, Snijders PJ,
Munoz N, Meijer CJ, Herrero R (2003). Role
of paan chewing and dietary habits in cer -
vical carcinoma in Chennai, India. Br J
Cancer 88: 1388-1393.
2325. Raju U, Shah V, Perveen N, Linden M
(2001). Evaluation of Breast Core Needle
Biopsies with CK 5/6, E-cadherin and
Calponin. Mod Pathol 14: 34A.
2326. Raju U, Vertes D (1996). Breast papil -
lomas with atypical ductal hyperplasia: a
clinicopathologic study. Hum Pathol 2 7 :
1231-1238.
2327. Raju UB, Lee MW, Zarbo RJ,
Crissman JD (1989). Papillary neoplasia of
the breast: immunohistochemically
defined myoepithelial cells in the diagnosis
of benign and malignant papillary breast
neoplasms. Mod Pathol 2: 569-576.
2327 a. Ramachandra S, Machin L, Ashley
S, Monaghan P, Gusterson BA (1990).
Immunohistochemical distribution of cerbB-2
in in situ breast carcinoma--a
detailed morphological analysis. J Pathol
161: 7-14.
2328. Ramaswamy S, Ross KN, Lander ES,
Golub TR (2003). A molecular signature of
metastasis in primary solid tumors. Nat
Genet 33: 49-54.
2329. Ramesh V, Iyengar B (1990).
Proliferating trichilemmal cysts over the
vulva. Cutis 45: 187-189.
2330. Ramos CV, Taylor HB (1974). Lipidrich
carcinoma of the breast. A clinicopathologic
analysis of 13 examples.
Cancer 33: 812-819.
2331. Ramsay J, Birrell G, Lavin M (1998).
Testing for mutations of the ataxia telangiectasia
gene in radiosensitive breast cancer
patients. Radiother Oncol 47: 125-128.
2332. Ramzy I (1976). Signet-ring stromal
tumor of ovary. Histochemical, light, and
electron microscopic study. Cancer 3 8 :
166-172.
2333. Randall ME, Kim JA, Mills SE, Hahn
SS, Constable WC (1986). Uncommon variants
of cervical carcinoma treated with
radical irradiation. A clinicopathologic
study of 66 cases. Cancer 57: 816-822.
2334. Rapin V, Contesso G, Mouriesse H,
Bertin F, Lacombe MJ, Piekarski JD,
Travagli JP, Gadenne C, Friedman S (1988).
Medullary breast carcinoma. A reevaluation
of 95 cases of breast cancer with
inflammatory stroma. Cancer 61: 2503-
2510.
2335. Rasbridge SA, Gillett CE, Millis RR
(1993). Oestrogen and progesterone receptor
expression in mammary fibromatosis. J
Clin Pathol 46: 349-351.
2336. Rasbridge SA, Gillett CE, Sampson
SA, Walsh FS, Millis RR (1993). Epithelial
(E-) and placental (P-) cadherin cell adhesion
molecule expression in breast carcinoma.
J Pathol 169: 245-250.
2336 a. Rasbridge SA, Millis RR (1995).
Carcinoma in situ involving sclerosing
adenosis: a mimic of invasive breast carcinoma.
Histopathology 27: 269-273.
2337. Rasbridge SA, Millis RR, Sampson
SA, Walsh FS (1992). Epithelial cadherin
expression in breast carcinomas. J Pathol
167: 149.
2338. Rasmussen BB, Rose C, Thorpe SM,
Andersen KW, Hou-Jensen K (1985).
Argyrophilic cells in 202 human mucinous
breast carcinomas. Relation to histopathologic
and clinical factors. Am J Clin Pathol
84: 737-740.
2339. Rastkar G, Okagaki T, Twiggs LB,
Clark BA (1982). Early invasive and in situ
warty carcinoma of the vulva: clinical, his -
tologic, and electron microscopic study
with particular reference to viral association.
Am J Obstet Gynecol 143: 814-820.
2 3 4 0 . Rauscher FJ, III, Benjamin LE,
Fredericks WJ, Morris JF (1994). Novel
oncogenic mutations in the WT1 Wilms'
tumor suppressor gene: a t(11;22) fuses the
Ewing's sarcoma gene, EWS1, to WT1 in
desmoplastic small round cell tumor. Cold
Spring Harb Symp Quant Biol 59: 137-146.
2341. Reardon W, Zhou XP, Eng C (2001). A
novel germline mutation of the PTEN gene
in a patient with macrocephaly, ventricular
dilatation, and features of VATER association.
J Med Genet 38: 820-823.
2342. Rebbeck TR, Kantoff PW, Krithivas K,
Neuhausen S, Blackwood MA, Godwin AK,
Daly MB, Narod SA, Garber JE, Lynch HT,
Weber BL, Brown M (1999). Modification of
BRCA1-associated breast cancer risk by
the polymorphic androgen-receptor CAG
repeat. Am J Hum Genet 64: 1371-1377.
2343. Rebbeck TR, Levin AM, Eisen A,
Snyder C, Watson P, Cannon-Albright L,
Isaacs C, Olopade O, Garber JE, Godwin
AK, Daly MB, Narod SA, Neuhausen SL,
Lynch HT, Weber BL (1999). Breast cancer
risk after bilateral prophylactic oophorectomy
in BRCA1 mutation carriers. J Natl
Cancer Inst 91: 1475-1479.
2344. Rebbeck TR, Lynch HT, Neuhausen
SL, Narod SA, van't Veer L, Garber JE,
Evans G, Isaacs C, Daly MB, Matloff E,
Olopade OI, Weber BL (2002). Prophylactic
oophorectomy in carriers of BRCA1 or
BRCA2 mutations. N Engl J Med 346: 1616-
1622.
2345. Rebbeck TR, Wang Y, Kantoff PW,
Krithivas K, Neuhausen SL, Godwin AK,
Daly MB, Narod SA, Brunet JS, Vesprini D,
Garber JE, Lynch HT, Weber BL, Brown M
(2001). Modification of BRCA1- and
BRCA2-associated breast cancer risk by
AIB1 genotype and reproductive history.
Cancer Res 61: 5420-5424.
2346. Recht A, Rutgers EJ, Fentiman IS,
Kurtz JM, Mansel RE, Sloane JP (1998).
The fourth EORTC DCIS Consensus meeting
(Chateau Marquette, Heemskerk, The
Netherlands, 23-24 January 1998)--confer -
ence report. Eur J Cancer 34: 1664-1669.
2347. Reddy DB, Rao DB, Sarojini JS (1963).
Extra-ovarian granulosa cell tumour. J
Indian Med Assoc 41: 254-257.
2348. Redline RW, Hassold T, Zaragoza MV
(1998). Prevalence of the partial molar phenotype
in triploidy of maternal and paternal
origin. Hum Pathol 29: 505-511.
2349. Reich O, Pickel H, Tamussino K,
Winter R (2001). Microinvasive carcinoma
of the cervix: site of first focus of invasion.
Obstet Gynecol 97: 890-892.
2350. Reich O, Regauer S, Urdl W,
Lahousen M, Winter R (2000). Expression
of oestrogen and progesterone receptors
in low-grade endometrial stromal sarcomas.
Br J Cancer 82: 1030-1034.
2351. Reiner A, Reiner G, Spona J,
Schemper M, Holzner JH (1988).
Histopathologic characterization of human
breast cancer in correlation with estrogen
receptor status. A comparison of immunocytochemical
and biochemical analysis.
Cancer 61: 1149-1154.
2352. Reinfuss M, Stelmach A, Mitus J, Rys
J, Duda K (1995). Typical medullary carcinoma
of the breast: a clinical and pathological
analysis of 52 cases. J Surg Oncol
60: 89-94.
2353. Reitamo JJ, Scheinin TM, Hayry P
(1986). The desmoid syndrome. New
aspects in the cause, pathogenesis and
treatment of the desmoid tumor. Am J
Surg 151: 230-237.
2354. Renno SI, Moreland WS, Pettenati
MJ, Beaty MW, Keung YK (2002). Primary
malignant lymphoma of uterine corpus:
case report and review of the literature.
Ann Hematol 81: 44-47.
2355. Report of an Advisory Group on Nonionising
Radiation (2001). Electromagnetic
Fields and the Risk of Cancer. Doc NRBP,
Vol. 12(1): 3-179.
2356. Resnick M, Lester S, Tate JE, Sheets
EE, Sparks C, Crum CP (1996). Viral and
histopathologic correlates of MN and
MIB-1 expression in cervical intraepithelial
neoplasia. Hum Pathol 27: 234-239.
2357. Resta L, Maiorano E, Piscitelli D,
Botticella MA (1994). Lipomatous tumors of
the uterus. Clinico-pathological features of
10 cases with immunocytochemical study
of histogenesis. Pathol Res Pract 190: 378-
383.
2358. Revillion F, Bonneterre J, Peyrat J
(1998). ERBB2 oncogene in human breast
cancer and its clinical significance.
European Journal of Cancer 34: 791-808.
2359. Reymundo C, Toro M, Morales C,
Lopez-Beltran A, Nogales F, Nogales F Jr.
(1993). Hyaline globules in uterine malignant
mixed mullerian tumours. A diagnostic
aid? Pathol Res Pract 189: 1063-1066.
2 3 6 0 . Rhatigan RM, Mojadidi Q (1973).
Adenosquamous carcinomas of the vulva
and vagina. Am J Clin Pathol 60: 208-217.
2361. Rhatigan RM, Nuss RC (1985).
Keratoacanthoma of the vulva. Gynecol
Oncol 21: 118-123.
2361 a. Rhemtula H, Grayson W, van
Iddekinge B, Tiltman A (2001). Large-cell
neuroendocrine carcinoma of the uterine
cervix--a clinicopathological study of five
cases. S Afr Med J 91: 525-528.
2362. Rhodes AR, Mihm MC Jr., Weinstock
MA (1989). Dysplastic melanocytic nevi: a
reproducible histologic definition emphasizing
cellular morphology. Mod Pathol 2:
306-319.
2363. Ribeiro GG, Phillips HV, Skinner LG
(1980). Serum oestradiol-17 beta, testosterone,
luteinizing hormone and folliclestimulating
hormone in males with breast
cancer. Br J Cancer 41: 474-477.
2364. Rice BF, Barclay DL, Sternberg WH
(1969). Luteoma of pregnancy: steroidogenic
and morphologic considerations.
Am J Obstet Gynecol 104: 871-878.
2365. Rice LW, Berkowitz RS, Lage JM,
Goldstein DP, Bernstein MR (1990).
Persistent gestational trophoblastic tumor
after partial hydatidiform mole. Gynecol
Oncol 36: 358-362.
2366. Richard F, Pacyna-Gengelbach M,
Schluns K, Fleige B, Winzer KJ, Szymas J,
Dietel M, Petersen I, Schwendel A (2000).
Patterns of chromosomal imbalances in
invasive breast cancer. Int J Cancer 89:
305-310.
References 409